VIDEO: Fight for cheaper drugs continues in Pta
The draft policy was released by the Dti in August.
More than 1 000 people gathered in Pretoria and marched to the Department of Trade and Industry (Dti) in Sunnyside on Tuesday in support of the government’s effort to fix medicines patent laws.
The fix the patent laws coalition (FTPL), Doctors Without Borders SA (MSF) and Treatment Action Campaign (TAC) marched in a bid to ensure patients had access to cheaper medicines.
The department has proposed changes to patent laws that give drug manufacturers a monopoly on medicines by preventing generic manufacturers from copying their formulas, a practice that has driven the cost of medicines down in many developing countries.
ALSO READ: WARNING: New drug hits Pretoria schools
TAC General Secretary outside @the_dti #FixPatentLaw @SECTION27news @MSF_southafrica pic.twitter.com/xytBVcm3Uz
— TAC (@TAC) October 24, 2017
The protesters argued that most people who needed drugs were unable to afford treatment, resulting in many preventable deaths.
MSF access campaign advocacy advisor Claire Waterhouse said reform had been ongoing since 2009.
ALSO READ: Be wary of rape drugs – Brooklyn cops
“We are encouraged that a final policy and actual changes to the law finally seem to be imminent. We marched to support the steps taken by the Dti to protect public health but also to remind the Dti that people’s lives depend on the rapid conclusion of this law reform process.”
A powerful testimony from Sue Johnson who is battling multiple myeloma. She needs lenalidomide. It costs R75,000 per month. #FixPatentLaw pic.twitter.com/SmobJMoWga
— TAC (@TAC) October 26, 2017
She said until the relevant laws were amended, people would continue to suffer and die because they couldn’t access affordable medicines.
Powerful testimonies from 2 patients affected by our patent laws. Sue is forced to pay R75k for a med that is R1.9k in India. #Fixpatentlaw pic.twitter.com/Migip3GOIL
— Fix the Patent Laws (@FixPatentLaw) October 26, 2017
FTPL handed over its submission in support of the draft intellectual property policy, and a new price deferential report on the dire inaccessibility of cancer medicines due to patent barriers.
ALSO READ: Metro declares war on drugs in the city
Activist & XDR TB survivor Phumeza Tisile talks to @the_dti meeting about her terrible experience of being treated for XDR TB #FixPatentLaw pic.twitter.com/wTYU9QDB6r
— TAC (@TAC) October 26, 2017
The draft policy was released by the Dti in August.
“The draft policy paves the way for a new, progressive intellectual property regime in South Africa, 16 years after the signing of the Doha Declaration on Public Health – a critical international agreement confirming countries’ ability to amend their laws to incorporate public health safeguards,” said the group.
It said for the first time, the draft policy was clear on prioritising people’s constitutionally guaranteed right of access to healthcare services.
“We want the final policy to first and foremost engender the ethos of the constitution.”
ALSO READ: East man caught with drugs
TAC chairperson Sibongile Tshabalala said: “We marched in solidarity with all people who cannot access the medicines they need to give themselves a chance at life or to ease their suffering. We have lost comrades and friends simply because they couldn’t access the medicines they needed due to high prices driven by unwarranted patent monopolies.”
The march comes almost a year after the tragic passing of prominent FTPL activist, Tobeka Daki – a mother of two fighting breast cancer.
Daki could not afford trastuzumab, which cost almost R500 000 a year. There is no generic for the Roche-manufactured drug because it is protected by patent.
Hundreds of activists march today urging South Africa to amend patent laws to save lives #FixPatentLaw pic.twitter.com/OMSPQhsIta
— MSF Access Campaign (@MSF_access) October 24, 2017
A cancer medicines report released on Thursday highlights the patent problem.
The report indicates that 15 of the 24 highly-effective cancer drugs, were available as generics in India for less than half the price they were sold for in South Africa.
MSF cited an example of lenalidomide which would cost a South African R882 000 but was sold for less than R32 000 in India.
The protesters accused pharmaceutical companies of price-fixing and selling medicines at shocking prices.
@FixPatentLaw @Cancer_ZA do we need more proof of unethical behavior @the_dti to #Fixpatentlaw & @CompComSA to investigate high prices https://t.co/EHLGE6F87d
— Salome Meyer (@SalomeMeyer1) October 25, 2017
“The report confirms earlier research showing that South Africa grants large numbers of secondary patents on medicines that are often rejected in other countries – a critical factor driving the vast price differences on the same medicines in South Africa and India,” said MSF.
“People suffering from HIV, TB, epilepsy and mental illness are all affected by patent barriers, which make the finalising of patent law reform all the more urgent.”
Submission handed over to @the_dti and the people have spoken: we need affordable meds now! Finalise the policy & save lives. #fixpatentlaw pic.twitter.com/pdDRZeVzs7
— Fix the Patent Laws (@FixPatentLaw) October 24, 2017
“Luckily, it seems that the Dti has woken up to the fact that it’s time to put people’s health over pharmaceutical corporations profits. The cancer report indicates just how urgent this is, which is why we want to show our support for this draft policy. This is South Africa’s opportunity to be a global role model in this area and we are ready to push parliament next year to make this a reality,” said Salomé Meyer of the Cancer Alliance.
Do you have more information about the story? Please send us an email to editorial@rekord.co.za or phone us on 083 625 4114.
For free breaking and community news, visit Rekord’s websites:
For more news and interesting articles, like Rekord on Facebook, follow us on Twitter or Instagram